Skip to content
← Catalog

Yingzhong Li · Q4 response · 5-step LNP discovery methodology

5/16 Antibody Conference Q&A · Q4 (audience question about LNP discovery process). Yingzhong's response describes SunVax's 5-step methodology "一气呵成" (per speaking style notes · methodology clarity).

Type
quote
Domain
conference
Grade
conference
License
LIGHT_HOPE_proprietary
Provenance
m622_command_round_12_batch_d_2026-05-17
evidence_grade
B
category
founder_panel_qa
status
draft
instance_tag
sunvax-antibody-2025
quote_text
Yingzhong 5-step methodology (per panel transcript via user m624 canonical): Step 1: 设计 optimal formula sample 库 Step 2: 测试 → 选 top 组 → 设计下一轮 Step 3: target cell 测试 (T cell · 活化态 vs 静息态) Step 4: 候选 → mouse biodistribution Step 5: identify best one Methodology character: 多轮迭代 · 数千
panel
Antibody_Conference_2026_05_15_Q4
topic
lnp_discovery_methodology
significance
Founder's methodology transparency · 5-step process is reusable reference for any "how does your LNP work?" client question. The iterative nature (多轮迭代 · 数千 datapoints) signals scale of empirical inve
speaker_name
Yingzhong Li
speaker_affiliation
SunVax mRNA Therapeutics Inc.

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.